BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30570037)

  • 1. [Survival difference due to types of health coverage in breast cancer patients treated at a specialized cancer center in Medellín, Colombia].
    Egurrola-Pedraza JA; Gómez-Wolff LR; Ossa-Gómez CA; Sánchez-Jiménez V; Herazo-Maya F; García-García HI
    Cad Saude Publica; 2018 Dec; 34(12):e00114117. PubMed ID: 30570037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study.
    Liedke PE; Finkelstein DM; Szymonifka J; Barrios CH; Chavarri-Guerra Y; Bines J; Vasconcelos C; Simon SD; Goss PE
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):126-33. PubMed ID: 24165578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life and health literacy among adult primary care patients with subsidized or contributive health insurance in Colombia.
    Lemley SM; Castro-Diaz S; Cubillos L; Suárez-Obando F; Torrey WC; Uribe-Restrepo JM; Williams M; Marsch LA; Gómez-Restrepo C
    Rev Colomb Psiquiatr (Engl Ed); 2021 Jul; 50 Suppl 1(Suppl 1):22-29. PubMed ID: 34253502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of health insurance affiliation and socioeconomic status on cervical cancer survival in Bucaramanga, Colombia.
    Chayo I; Uribe Perez CJ; De Vries E; Pinheiro PS
    Cancer Epidemiol; 2023 Aug; 85():102375. PubMed ID: 37150101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health inequities and cancer survival in Manizales, Colombia: a population-based study.
    Arias-Ortiz NE; de Vries E
    Colomb Med (Cali); 2018 Mar; 49(1):63-72. PubMed ID: 29983465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Health Inequities on Population-Based Breast Cancer Survival in a Colombian Population, 2008-2015.
    Arias-Ortiz N; Rodríguez-Betancourt JD; Toro-Toro JE; Navarro-Lechuga É; Jurado-Fajardo DM; Cárdenas-Garzón K; Sánchez-Vásquez GI
    Cancer Control; 2024; 31():10732748241244928. PubMed ID: 38557156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Delay for diagnosis and treatment of breast cancer in Bogotá, Colombia].
    Piñeros M; Sánchez R; Perry F; García OA; Ocampo R; Cendales R
    Salud Publica Mex; 2011; 53(6):478-85. PubMed ID: 22282140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The impact of subsidized healthcare insurance on access to cervical cytology in Medellin, Colombia].
    Atehortúa SC; Palacio-Mejía LS
    Rev Salud Publica (Bogota); 2014; 16(4):522-33. PubMed ID: 25791304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
    Chlebowski RT; Blackburn GL; Thomson CA; Nixon DW; Shapiro A; Hoy MK; Goodman MT; Giuliano AE; Karanja N; McAndrew P; Hudis C; Butler J; Merkel D; Kristal A; Caan B; Michaelson R; Vinciguerra V; Del Prete S; Winkler M; Hall R; Simon M; Winters BL; Elashoff RM
    J Natl Cancer Inst; 2006 Dec; 98(24):1767-76. PubMed ID: 17179478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying barriers to move to better health coverage: preferences for health insurance benefits among the rural poor population in La Guajira, Colombia.
    Amaya JL; Ruiz F; Trujillo AJ; Buttorff C
    Int J Health Plann Manage; 2016; 31(1):126-38. PubMed ID: 25111823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia.
    Sanabria M; Muñoz J; Trillos C; Hernández G; Latorre C; Díaz CS; Murad S; Rodríguez K; Rivera A; Amador A; Ardila F; Caicedo A; Camargo D; Díaz A; González J; Leguizamón H; Lopera P; Marín L; Nieto I; Vargas E
    Kidney Int Suppl; 2008 Apr; (108):S165-72. PubMed ID: 18379541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort.
    Ossa CA; Herazo F; Gil M; Echeverri C; Ángel G; Borrero M; Madrid J; Jaramillo R
    Colomb Med (Cali); 2015 Sep; 46(3):104-8. PubMed ID: 26600624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
    Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment variation by insurance status for breast cancer patients.
    Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
    Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.
    Mittendorf EA; Ballman KV; McCall LM; Yi M; Sahin AA; Bedrosian I; Hansen N; Gabram S; Hurd T; Giuliano AE; Hunt KK
    J Clin Oncol; 2015 Apr; 33(10):1119-27. PubMed ID: 25488970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the universal health insurance benefits on cervical cancer mortality in Colombia.
    Lewis AGC; Hernandez DM; Garcés-Palacio IC; Soliman AS
    BMC Health Serv Res; 2024 May; 24(1):693. PubMed ID: 38822370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of insurance status on presentation, surgical management, and mortality among nonmetastatic breast cancer patients in Indiana.
    Obeng-Gyasi S; Timsina L; Miller KD; Ludwig KK; Fisher CS; Haggstrom DA
    Surgery; 2018 Dec; 164(6):1366-1371. PubMed ID: 30170816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the Use of the Human Recombinant Epidermal Growth Factor in the Subsidized Regime vs The Contributive Regime in Patients with Venous Ulcers in Bogotá.
    Cacua Sanchez MT; Buenahora G; Carrillo Bravo CA
    Drug Des Devel Ther; 2024; 18():1933-1945. PubMed ID: 38831868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy.
    Raphael J; Paramsothy T; Li N; Lee J; Gandhi S
    Breast Cancer Res Treat; 2017 May; 163(1):11-19. PubMed ID: 28243899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.